EARLY NOVEMBER UPDATE: AGRIGLOW BIOTECH EARLY RESULTS – REVENUE STREAMS
LETTER TO THE SHAREHOLDERS EARLY NOVEMBER UPDATE: AGRIGLOW BIOTECH EARLY RESULTS – REVENUE STREAMS November 11, 2024 Napoleonville, LA IFUS:OTC Impact Fusion is pleased to announce progress on several fronts as reported by the team from AgriGlow Biotech in India. The initial trial being conducted in Sumul, India has proven successful. Our intent was to introduce the SGP+2.0™ formulation to determine herd acceptance. As expected with any herd of cows, different herds react differently to changes in their normal nutritional ration. A slight change in taste, smell, and/or texture can be initially off-putting to certain herds, where other herds immediately gobble up the new ration. Initial acceptance by the India test group was initially slow. However, once accepted not only did the heifers gobble the ration, but so did a calf as previously reported. The acceptance of forage-type ration for a calf has been shown in other beef cattle trials to be of paramount importance: a. Positive impacts on calf health, weight-gain, and overall well-being. b. Reduction in post-partum infant mortality. c. The earlier the weaning time of the calf from the mother, allows for a shortened gestational cycle to a new pregnancy. As a result, the average mother heifer